Fox Rothschild LLP advised PharmaCann on the deal.Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) and PharmaCann Inc. (“PharmaCann”), one of the largest vertically integrated cannabis companies in…
Standard 1 Year Membership Required
You must be a Standard 1 Year member to access this content.
Already a member? Log in here
